Secondary Logo

Journal Logo

Most Popular Articles

Antitumor Potency of an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, Lisocabtagene Maraleucel in Combination With Ibrutinib or Acalabrutinib

Qin, Jim S.; Johnstone, Timothy G.; Baturevych, Alex; More

Journal of Immunotherapy. 43(4):107-120, May 2020.

Generation of Antitumor T Cells For Adoptive Cell Therapy With Artificial Antigen Presenting Cells

Shrestha, Bishwas; Zhang, Yongliang; Yu, Bin; More

Journal of Immunotherapy. 43(3):79-88, April 2020.

Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment

Diem, Stefan; Fässler, Mirjam; Bomze, David; More

Journal of Immunotherapy. 42(3):89-93, April 2019.

CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial Diagnosis

Fischer, Jeannette; Paret, Claudia; El Malki, Khalifa; More

Journal of Immunotherapy. 40(5):187-195, June 2017.

A Clinical Development Paradigm for Cancer Vaccines and Related Biologics

Hoos, Axel; Parmiani, Giorgio; Hege, Kristen; More

Journal of Immunotherapy. 30(1):1-15, January 2007.

Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity

Fotin-Mleczek, Mariola; Duchardt, Katharina M.; Lorenz, Christina; More

Journal of Immunotherapy. 34(1):1-15, January 2011.

Treatment With Tumor-infiltrating Lymphocytes in Advanced Melanoma: Evaluation of Early Clinical Implementation of an Advanced Therapy Medicinal Product

Lindenberg, Melanie A.; Retèl, Valesca P.; van den Berg, Joost H.; More

Journal of Immunotherapy. 41(9):413-425, November/December 2018.

Hemofiltration Successfully Eliminates Severe Cytokine Release Syndrome Following CD19 CAR-T-Cell Therapy

Liu, Yanfen; Chen, Xinfeng; Wang, Dao; More

Journal of Immunotherapy. 41(9):406-410, November/December 2018.

Workshop on Cancer Biometrics: Identifying Biomarkers and Surrogates of Cancer in Patients: A Meeting Held at the Masur Auditorium, National Institutes of Health

Lotze, Michael T; Wang, Ena; Marincola, Francesco M; More

Journal of Immunotherapy. 28(2):79-119, March-April 2005.

Homing of Tumor-Specific T Cells in the B16-OVA/OT-I Model System - towards T Cells as Carriers of Cytotoxic Substances in Therapy of Cancer

Petersen, Mikkel S; Fleischer, Charlotte C; Hansen, Søren B; More

Journal of Immunotherapy. 27(6):S36, November-December 2004.

Whole Recombinant Saccharomyces cerevisiae Yeast Expressing Ras Mutations as Treatment for Patients With Solid Tumors Bearing Ras Mutations: Results From a Phase 1 Trial

Cohn, Allen; Morse, Michael A.; O’Neil, Bert; More

Journal of Immunotherapy. 41(3):141-150, April 2018.

Patched 1-interacting Peptide Represses Fibrosis in Pancreatic Cancer to Augment the Effectiveness of Immunotherapy

Oyama, Yasuhiro; Onishi, Hideya; Koga, Satoko; More

Journal of Immunotherapy. 43(4):121-133, May 2020.

DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft Rejection

Chandra, Janin; Dutton, Julie L.; Li, Bo; More

Journal of Immunotherapy. 40(2):62-70, February/March 2017.

IL-2−driven Regulation of NK Cell Receptors With Regard to the Distribution of CD16+ and CD16− Subpopulations and In Vivo Influence After Haploidentical NK Cell Infusion

Huenecke, Sabine; Zimmermann, Stefanie Yvonne; Kloess, Stephan; More

Journal of Immunotherapy. 33(2):200-210, February-March 2010.

An IgG1 Version of the Anti-transferrin Receptor 1 Antibody ch128.1 Shows Significant Antitumor Activity Against Different Xenograft Models of Multiple Myeloma: A Brief Communication

Daniels-Wells, Tracy R.; Candelaria, Pierre V.; Leoh, Lai Sum; More

Journal of Immunotherapy. 43(2):48-52, February/March 2020.

A Severe, Refractory Case of Mucous Membrane Pemphigoid After Treatment With Pembrolizumab: Brief Communication

Bezinelli, Letícia Mello; Eduardo, Fernanda P.; Migliorati, Cesar A.; More

Journal of Immunotherapy. 42(9):359-362, November/December 2019.

Early Experience With CliniMACS Prodigy CCS (IFN-gamma) System in Selection of Virus-specific T Cells From Third-party Donors for Pediatric Patients With Severe Viral Infections After Hematopoietic Stem Cell Transplantation

Kállay, Krisztián; Kassa, Csaba; Réti, Marienn; More

Journal of Immunotherapy. 41(3):158-163, April 2018.

Potent Control of Tumor Growth by CEA/CD3-bispecific Single-chain Antibody Constructs That Are Not Competitively Inhibited by Soluble CEA

Lutterbuese, Ralf; Raum, Tobias; Kischel, Roman; More

Journal of Immunotherapy. 32(4):341-352, May 2009.

Immunologic Monitoring of Cancer Vaccine Therapy: Results of a Workshop Sponsored by the Society for Biological Therapy

Keilholz, Ulrich; Weber, Jeffrey; Finke, James H.; More

Journal of Immunotherapy. 25(2):97-138, March-April 2002.

Cancer and Inflammation: Promise for Biologic Therapy

Demaria, Sandra; Pikarsky, Eli; Karin, Michael; More

Journal of Immunotherapy. 33(4):335-351, May 2010.

The Role of Extracellular Spacer Regions in the Optimal Design of Chimeric Immune Receptors: Evaluation of Four Different scFvs and Antigens

Guest, Ryan D; Hawkins, Robert E; Kirillova, Natalia; More

Journal of Immunotherapy. 28(3):203-211, May-June 2005.

The Immune Adjuvant Properties of Front-line Carboplatin-Paclitaxel: A Randomized Phase 2 Study of Alternative Schedules of Intravenous Oregovomab Chemoimmunotherapy in Advanced Ovarian Cancer

Braly, Patricia; Nicodemus, Christopher F.; Chu, Christina; More

Journal of Immunotherapy. 32(1):54-65, January 2009.

Identification of a Promiscuous Epitope Peptide Derived From HSP70

Matsui, Hiroto; Hazama, Shoichi; Tamada, Koji; More

Journal of Immunotherapy. 42(7):244-250, September 2019.

Updated Technology to Produce Highly Immunogenic Dendritic Cell-derived Exosomes of Clinical Grade: A Critical Role of Interferon-γ

Viaud, Sophie; Ploix, Stéphanie; Lapierre, Valérie; More

Journal of Immunotherapy. 34(1):65-75, January 2011.

Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL

Boeck, Corinna L.; Amberger, Daniel C.; Doraneh-Gard, Fatemeh; More

Journal of Immunotherapy. 40(6):224-248, July/August 2017.

PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors

Soares, Kevin C.; Rucki, Agnieszka A.; Wu, Annie A.; More

Journal of Immunotherapy. 38(1):1-11, January 2015.

Dendritic Cells Generated in Clinical Grade Bags Strongly Differ in Immune Functionality When Compared With Classical DCs Generated in Plates

Rouas, Rédouane; Akl, Haidar; Fayyad-Kazan, Hussein; More

Journal of Immunotherapy. 33(4):352-363, May 2010.

Preparation of Cytokine-activated NK Cells for Use in Adoptive Cell Therapy in Cancer Patients: Protocol Optimization and Therapeutic Potential

van Ostaijen-ten Dam, Monique M.; Prins, Henk-Jan; Boerman, Gerharda H.; More

Journal of Immunotherapy. 39(2):90-100, February/March 2016.

DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma

Leaf, Rebecca Karp; Stroopinsky, Dina; Pyzer, Athalia R.; More

Journal of Immunotherapy. 40(9):315-322, November/December 2017.

Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients

Boudewijns, Steve; Westdorp, Harm; Koornstra, Rutger H.T.; More

Journal of Immunotherapy. 39(6):241-248, July/August 2016.

Oligodeoxynucleotide CpG 7909 Delivered as Intravenous Infusion Demonstrates Immunologic Modulation in Patients With Previously Treated Non-Hodgkin Lymphoma

Link, Brian K.; Ballas, Zuhair K.; Weisdorf, Daniel; More

Journal of Immunotherapy. 29(5):558-568, September-October 2006.

Show: